|
|
|
Volumn 13, Issue 2, 1998, Pages 93-110
|
|
New advances in the pathogenesis and therapy of bronchial asthma
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
ANTIINFLAMMATORY AGENT;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
CYTOKINE;
IMMUNOGLOBULIN E ANTIBODY;
INTERLEUKIN 1BETA;
INTERLEUKIN 4;
INTERLEUKIN 5;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
NEDOCROMIL SODIUM;
TUMOR NECROSIS FACTOR ALPHA;
ALLERGIC ASTHMA;
ANIMAL MODEL;
BRONCHUS HYPERREACTIVITY;
CORTICOSTEROID THERAPY;
DISEASE PREDISPOSITION;
EXPERIMENTAL MODEL;
HUMAN;
IMMUNOTHERAPY;
INFLAMMATION;
INHALATIONAL DRUG ADMINISTRATION;
MOUSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
REVIEW;
SENSITIZATION;
ANIMALS;
ASTHMA;
CHEMOKINES;
CYTOKINES;
DISEASE MODELS, ANIMAL;
DISEASE SUSCEPTIBILITY;
EOSINOPHILS;
HUMANS;
IMMUNOGLOBULIN E;
INFLAMMATION;
MAST CELLS;
MICE;
TH2 CELLS;
|
|
EID: 0031849217
PISSN: 03939340
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (98)
|
